Understanding Urethral Cancer
A guide for adults, men and women, diagnosed with or under workup for urethral cancer. It covers the diagnosis, the choices, and the life that comes after.
Welcome
Urethral cancer is uncommon, and in its early stages the symptoms look like much more common problems such as a stricture, a stubborn urinary infection, or an enlarged prostate. Many people are treated for one of those before a cystoscopy or biopsy shows the cancer. That overlap with more common conditions is a feature of how this disease presents.
Urethral cancer is rare. Only about 1 or 2 out of every million people get it in a given year. Because it is rare, very few people you meet will know much about it, and even some clinicians have never seen a case. That rarity changes the path forward in two ways. It means a second opinion at a high-volume center is reasonable for almost any invasive case. And it means a lot of what we offer is borrowed from the way we treat bladder cancer, penile cancer, and anal cancer. We will say so plainly when it matters.
This guide covers urethral cancer in both men and women in one place. The anatomy is different, and the choices are different, so each chapter labels the parts that apply to men and the parts that apply to women. Read it once at your own pace. Skip what does not fit your situation.
This guide pairs with the Cancer Basics guide, which explains the general words and ideas that go with any cancer. Read that one first if you have not yet.
How to use this guide. Read it once at your own pace, highlight what fits your situation, and bring the questions in Chapter 14 to your next visit. You do not have to remember any of this. It is here whenever you need to look something up.
What urethral cancer is
Urethral cancer is a rare cancer of the tube that carries urine from the bladder out of the body. Where you are treated changes what is offered and how well it goes.
What the urethra is and where cancer starts
The urethra is the tube that carries urine from the bladder out of the body. In men, it runs through the prostate, then the perineum (the area between the scrotum and the anus), then down through the penis. In women, it is much shorter, about an inch and a half, and runs from the bladder to a small opening just above the vagina.
Cancer can start anywhere along the urethra. The inside of the tube is not all the same kind of tissue, and the type of cancer depends on which part of the urethra it starts in. The three main types:
- Urothelial cancer. The most common type overall, about half of cases. It tends to start in the part of the urethra closer to the bladder. In men, that is the part that runs through the prostate. In women, it is the third closest to the bladder. This is the same kind of cancer that starts in the bladder lining.
- Squamous cell cancer. About 15 to 30 out of 100 cases. It tends to start in the part of the urethra farther from the bladder. In men, that is the bulbar and penile parts. In women, it is the two-thirds of the urethra closer to the outside opening. This kind is linked to long-term irritation, scarring, and the human papillomavirus (HPV).
- Adenocarcinoma. About 10 to 15 out of 100 cases. It comes from small glands that sit alongside the urethra. In women, it is often found inside a pouch along the urethra called a diverticulum.
Other rare types (like melanoma or sarcoma) make up less than 5 out of 100 cases. They are not the focus of this guide.
How rare it is
Urethral cancer makes up only about 1 or 2 out of every 100 cancers of the urinary tract. About 4 cases per million men each year, and about 1 to 2 per million women. The typical age at diagnosis is the mid-60s to mid-70s.
Why the outlook depends on stage and location
- Small cancers near the outside opening of the urethra. Especially in women, these have some of the best results in the disease. Around 70 to 90 out of 100 people are alive at 5 years.
- Cancers deeper in the urethra, closer to the bladder, or growing into nearby tissue. Survival drops into a wide range, often 30 to 50 out of 100 at 5 years.
- Cancer in the lymph nodes or in distant organs. The number drops further, often under 20 out of 100 at 5 years.
Primary cancer vs cancer that comes back after a bladder is removed
This guide covers cancer that starts in the urethra. A different group of patients had their bladder removed for bladder cancer years ago and develop a new urothelial cancer in the urethra after that surgery. The risk of this is about 5 to 10 out of 100 over a lifetime. The workup and treatment for that situation share a lot with this guide, but the long-term care is run by your bladder cancer team. Chapter 12 picks this up.
Most people walk in with some mix of feelings. There can be relief at having a name for the problem, fear about how voiding and sex will change, confusion at a cancer few people have heard of, and worry about the people at home. Bring whichever ones you are carrying into the first visit.
Who gets it, and why
The main risk factors are long-term irritation of the urethra, a past bladder cancer, HPV, and pelvic radiation. The mix is different for men and women.
Long-term irritation of the urethra
This is the strongest risk you can change in men. It is most tied to squamous cancer of the bulbar urethra. That is the part of the urethra in the perineum. A long-term scar narrowing is called a urethral stricture. Stricture, repeat dilations, long-term catheters, and ongoing urine infections all keep the urethra inflamed for years. The lag is long, often 15 to 20 years from the first stricture to a cancer.
A past bladder cancer
If you have had bladder cancer, the lining cells in the urethra can also turn cancerous over time. After the bladder is removed for cancer, the urethra is the part most often missed by routine scans. That is why teams keep an eye on it on a set schedule.
HPV (human papillomavirus)
HPV-16 is the type most often tied to squamous cancer of the distal urethra. That is the part farther from the bladder. The same link shows up in penile and anal squamous cancers. Tumor tissue is often tested for HPV at big centers.
Pelvic radiation in the past
Radiation for prostate, gynecologic, or anal cancer years earlier raises the risk of a later urethral cancer. The lag is typically 10 to 20 years. This is part of why old radiation history is asked for at the first visit.
A urethral diverticulum (women)
A diverticulum is a small pouch along the urethra. They are most common in women. Most diverticula are not cancerous. A small share of them harbor an adenocarcinoma that comes from the gland tissue in the wall of the pouch. Any new mass, blood, or new pain in a known diverticulum needs imaging and a biopsy.
Lichen sclerosus
Lichen sclerosus is a long-term inflammatory skin condition that affects the head of the penis and foreskin in men and the vulva in women. Over many years, it raises the risk of squamous cancer of the distal urethra in both men and women, which is why long-term skin and urology care matters.
Long-term catheter use and ongoing infections
A few things add up over the years and keep the urethra irritated. These include long-term Foley catheters, putting a catheter in yourself a few times a day for a bladder that has lost its nerve signal, and many urinary infections. That long irritation can lead to squamous cancer. It is most common in people with spinal cord injury.
Smoking
This is the classic risk factor for urothelial cancer. It applies to the whole urinary tract, including the urethra. Quitting smoking lowers the risk over years.
Sex and age
Men are diagnosed two to three times as often as women. The types of cancer they get are also different. Men more often get cancer in the bulbar urethra (squamous) and the prostatic urethra (urothelial). Women more often get distal squamous cancer near the opening. They also more often get gland-type cancer inside a pouch. The typical age is the mid-60s to mid-70s.
The HPV shot at age 11 or 12 (catch-up through 26) protects boys and girls equally. It blocks cancers that show up decades later, including some urethral cancers. As with the penile cancer guide, this is one place where what you do today changes things for the next generation.
The symptoms, and why this cancer hides
The symptoms of urethral cancer look like much more common problems. That overlap is the central feature of how it presents.
What patients usually notice
Men
- Blood in the urine. Blood at the tip of the penis between voids.
- A slow stream that does not get better after a dilation, or that gets worse again soon.
- Recurrent urinary infections.
- A lump or thickening felt along the penis or in the perineum.
- Aching in the perineum that does not go away.
- Discharge from the urethra that is not from an infection.
- A "stricture" that keeps coming back after each treatment.
Women
- Blood at the urethral opening or in the urine.
- Sudden urges to go, and going often, much like a urine infection that keeps coming back.
- Pain with intercourse, especially along the front wall of the vagina.
- A lump felt along the front wall of the vagina during hygiene or sex.
- New stress incontinence (leaking with cough or laugh).
- Leaking a few drops after you go, more so if there is a pouch along the urethra.
- A visible growth at the urethral opening.
Both
- A lump felt in the groin.
- Weight loss or pain in the pelvis.
Why it looks like something else
In men, the symptoms look like a stricture. In women, they look like a urinary infection. Those more common problems get treated first. Because the symptoms overlap so much, the diagnosis often takes several visits and tests. The cancer is often found when a cystoscopy is done for a stricture that will not stay open, or for an infection that will not clear.
The rule that helps catch this cancer earlier
Some strictures need a look inside the urethra with a small camera, plus a biopsy of anything that looks off. That covers five settings. A stricture that comes back fast after each dilation. A stricture with no clear cause. A stricture that bleeds or weeps. A stricture in someone with past bladder cancer or pelvic radiation. A "stricture" in a woman, since true strictures in women are much less common than cancer.
What it often gets called by mistake
Men
Urethral stricture. Enlarged prostate (benign prostatic hyperplasia, or BPH). Bladder neck scar after prostate surgery. Long-term prostatitis. Periurethral abscess. Lichen sclerosus with a tight opening. Genital warts. Each of these is more common than urethral cancer. The catch-all rule is that any sore, mass, or stubborn problem in the urethra that does not respond to the treatment for one of these conditions deserves a cystoscopy and a biopsy.
Women
Recurrent urinary infection. Thinning of the urethral lining from menopause. A urethral caruncle (a small benign growth at the opening). A urethral diverticulum. A vaginal wall cyst. A vaginal wart. The catch-all rule is the same. New blood at the urethra, a new mass felt along the vagina or at the opening, or a mass found in a known diverticulum deserves imaging and a biopsy.
Red flags that need a faster look
- A stricture that comes back within months despite treatment.
- Any growth seen in the urethra on cystoscopy, even a small one.
- Blood in the urine when the kidneys and bladder are normal but no one has looked carefully at the urethra.
- A firm or fixed lump along the urethra in either sex.
- A new mass in a known diverticulum.
- A dark spot at the urethral opening. Melanoma is rare but serious.
- A new opening on the skin where urine leaks out, in someone with no recent surgery or scope.
Workup, biopsy, and staging
The workup confirms the cancer with a piece of tissue. It maps the tumor and how deep it goes. It checks the lymph nodes and the rest of the body for spread.
History and exam
Your team will ask how long the symptoms have been there and what was tried for them. They will ask about past urethral procedures or catheters, and about past bladder cancer or pelvic radiation. They will also ask about smoking, the HPV vaccine, and any weight loss, bone pain, or fatigue.
The exam is full and specific.
- Men. The opening at the tip of the penis is checked. The length of the urethra is felt along the penis, the bulbar segment, and the membranous segment for any thickening or mass. Both groins are felt with care for lymph nodes.
- Women. The opening of the urethra is checked. The front wall of the vagina is felt along the full length of the urethra for any mass or pouch. A pelvic exam is done. Both groins are checked.
Cystoscopy with biopsy
This is the test that names the cancer. A thin camera goes through the urethra to look at the lining and the bladder. The first look is often in the office with local numbing jelly. A second look in the operating room is usually done. It allows a careful biopsy of the lesion, a check for the depth of invasion, and a check for any other spots in the bladder. In women, the team often does a careful exam under anesthesia at the same time, with two-handed feel of the urethra and front vaginal wall, to judge how mobile the tumor is.
Urine cytology
A urine sample looked at under the microscope for cancer cells. It is most useful for urothelial cancers. Three voided samples on different days raise the chance of catching high-grade cells.
Imaging the cancer itself
An MRI of the pelvis is the most useful test for mapping the cancer. It shows how deep the cancer has gone into the tissue around the urethra. In men, it shows if the cancer has reached the spongy or erection tissue. In women, it shows if it has reached the front wall of the vagina. It also shows if it has reached the prostate or the bladder. This MRI is the most useful test for deciding if organ-sparing surgery is still on the table. Some centers add a special MRI of the penis with an erection when the cancer is in the distal urethra in a man.
Imaging the nodes and the rest of the body
- Early-stage distal cancer with normal-feeling groin nodes. The groins are checked by feel and often by ultrasound. A CT of the chest, belly, and pelvis is usually done as well, since urethral cancer is often more advanced under the microscope than it looks on the surface.
- Deeper cancer, even with normal-feeling groins. A CT of the chest, belly, and pelvis with contrast is standard.
- Felt or large groin nodes. Same CT, plus a needle sample or excisional biopsy of the felt node. A PET scan is sometimes added when the nodes are large or on both sides.
- Bone or unusual symptoms. A bone scan or PET scan as needed.
How stage is described
Stage is built from the T, N, and M of the cancer: the T describes how deep the cancer has gone, the N describes the lymph nodes, and the M describes spread to far parts of the body. The Cancer Basics guide explains TNM. For urethral cancer:
- Tis (carcinoma in situ) and Ta. Cancer is confined to the surface lining of the urethra.
- T1. Invades the thin layer just below the surface.
- T2. Grows into the spongy tissue around the urethra. Or into the prostate in men. Or into the muscle layer around the urethra.
- T3. Grows into the deeper parts. That can mean the deep erection tissue, past the prostate, into the front of the vagina, or into the neck of the bladder.
- T4. Grows into the bladder or into other nearby organs.
Where the cancer drains to (and so where it can spread first) depends on where it sits. Cancer in the distal urethra (closer to the outside opening) drains to the groin lymph nodes. Cancer in the proximal urethra (closer to the bladder) drains to lymph nodes in the pelvis. This shapes which scans are needed and which lymph nodes the surgery will address.
Why the stage on paper can be lower than the true stage
Urethral cancer is often more advanced under the microscope than the MRI showed. Up to 30 to 50 out of 100 patients have a higher stage on the final lab report than was expected. Your team plans for this. It matters most when the surgery sits near the line between organ-sparing and a bigger operation.
Bring it to your next visit. The type, the grade, the depth, and any risk features all drive what comes next. Your team will walk through it line by line.
Treatment options
Treatment planning covers three questions: what to do for the cancer itself, what to do for the lymph nodes, and whether to add chemotherapy before or after surgery. Your team decides each one from where the cancer sits, how deep it goes, and which of the three main types it is.
The two big rules
The location of the cancer matters more than the type when picking the operation. The type of cancer matters more than the location when picking the chemotherapy.
- Cancers near the outside opening (the distal urethra). These are more often treated with organ-sparing surgery.
- Cancers in the part closer to the bladder (the proximal urethra). These more often need a bigger operation. Chemo before surgery is sometimes added.
- Urothelial cancer is treated using ideas from bladder cancer. A drug called cisplatin is the base of the chemo.
- Squamous cancer is treated using ideas from anal cancer. Two chemo drugs with radiation (the Nigro plan) can save the bladder and urethra.
- Adenocarcinoma is treated case by case. The evidence is thinnest.
Options by stage and location
| Stage and location | What is usually offered | The trade |
|---|---|---|
| Tis or Ta (cancer on the surface lining only) | Removal in the office with a small instrument. Laser. For urothelial Tis in the prostatic urethra, bacillus Calmette-Guerin (BCG), a treatment placed inside the urethra. Topical creams for distal disease in select cases. | Organ-sparing. Cancer can come back, so close follow-up cystoscopies are part of the plan. |
| Early cancer in the distal urethra (men) | Removal of just the affected part of the urethra. For longer distal disease, removal of the distal urethra with a new opening in the perineum (perineal urethrostomy). For cancer in the head of the penis, the penile cancer options apply. | Organ-sparing. Voiding may shift to seated. Sex and feeling in the penis are usually kept. |
| Early cancer in the distal urethra (women) | Removal of the distal one to two thirds of the urethra. Continence is usually kept as long as the bladder neck and a short segment of urethra closer to the bladder are kept intact. | Organ-sparing. Small distal cancers in women have some of the best results in the disease. Stress incontinence is the most common change. |
| Deeper or proximal cancer in men | Removal of the bladder, prostate, and urethra together, with a new way for urine to leave the body (a urinary diversion). For some men, removal of the penis with a perineal urethrostomy is the right operation. | Bigger operation. Sex and the way you urinate both change. Chemotherapy before surgery is often added. |
| Deeper or proximal cancer in women | Removal of the bladder, urethra, and front wall of the vagina, with a urinary diversion. Sometimes the uterus and ovaries are removed too. The vagina can be rebuilt at the same operation. | Bigger operation with a long recovery. Sex life changes. Chemotherapy before surgery is often added. |
| Squamous distal cancer (either sex) | Chemotherapy plus radiation (the Nigro protocol, used for anal cancer) as a way to keep the urethra. Surgery is held in reserve for cancer that does not respond. | The body part is kept if the treatment works. Late effects on the urethra, soft tissue, and sex function do happen. |
| Advanced or spread disease | Chemotherapy by type of cancer. Newer drugs for urothelial cancer (antibody-drug treatments, immune drugs, targeted drugs). Clinical trials. | The aim is control of the cancer and quality of life rather than cure for most spread disease. |
About surgical margins
Older rules called for wide margins of normal tissue around the cancer. The newer rule is that a clean margin of a few millimeters is enough. Many centers use frozen-section checks during surgery to confirm the margin is clean before they close. This is why modern organ-sparing surgery keeps more of the urethra than older operations did.
Where these treatments come from
Many parts of this plan come from other cancers, because urethral cancer is too rare to study on its own.
- The chemo for urothelial urethral cancer is the same as for bladder cancer.
- Squamous cancer gets chemo and radiation. That plan comes from anal cancer care.
- For squamous urethral cancer, the chemo before surgery is called TIP. It comes from penile cancer care.
- The way we check lymph nodes for squamous distal urethral cancer comes from penile cancer.
This is normal for rare cancers. Ask your team which parts of your plan come from urethral cancer studies and which come from other cancers.
Surgery vs chemoradiation
For squamous cancer of the distal urethra, two paths can preserve the urethra. The classic path is surgery, and the newer one is chemotherapy plus radiation borrowed from anal cancer. Each path has costs, laid out below.
Why this choice exists
Squamous urethral cancer acts much like squamous anal cancer. Anal cancer has a long-standing plan called the Nigro protocol. It uses two chemo drugs (5-FU and mitomycin C) with focused radiation. It cures most early anal cancers and saves the bowel. Some centers have adapted this same idea for squamous urethral cancer. The goal is to control the cancer and save the urethra and bladder.
What the data show
The studies are smaller than for anal cancer and come from a small number of centers. In the patients picked for it, the protocol controls the cancer at the same spot in roughly 60 to 80 out of 100 cases over the next few years. Patients whose cancer does not respond go on to surgery, which still gives a chance at cure.
Side effects table, side by side
| Surgery (urethrectomy or bigger) | Chemotherapy plus radiation | |
|---|---|---|
| Time to treatment | Days to a few weeks after staging. | Two to three weeks to start. Five to six weeks of radiation, with the chemotherapy in the first week and again later. |
| Hospital time | Several days for a big operation. Outpatient or one night for distal surgery. | Outpatient most days. Hospital stays are short and only if side effects need it. |
| Short-term effects | Pain at the site. Wound issues. Catheter for a stretch. | Skin irritation in the area treated. Nausea. Drop in blood counts during chemotherapy. |
| Long-term effects on the urethra | Change in how and where you urinate. Possible narrowing at the new connection. | Long-term scarring of the urethra. Narrowing. Sometimes a new opening (called a fistula) needs repair. |
| Long-term effects on sex | Depends on the operation. See Chapter 8. | Erectile changes in men. Vaginal dryness and narrowing in women. Both can be managed. |
| Effect on the bladder | Bladder kept (for organ-sparing). Bladder removed for proximal disease. | Bladder kept in most cases. Radiation-related bladder symptoms are possible. |
| If treatment does not control the cancer | Salvage with chemotherapy plus radiation, or with bigger surgery. | Salvage with surgery (urethrectomy, sometimes bigger). |
| Where it is offered | Most cancer programs. | A small number of high-volume centers. |
How the choice is made
The choice depends on the type of cancer. It also depends on where it sits, how deep it goes, your other health issues, and what matters to you. For squamous cancer in the distal part of the urethra, many doctors lean toward chemo plus radiation. It can keep the urethra and the bladder in place when it works. For urothelial cancer, surgery is more standard. Chemo before surgery is often added. Chemo plus radiation has a much smaller track record for this type.
How many urethral cancers does this center treat with chemotherapy plus radiation each year? How many of those patients still have the cancer controlled at three and five years? The numbers are small even at high-volume programs, often a handful of cases per year. A specific answer like "we see two or three of these a year" tells you more than a general reassurance.
The lymph nodes
Whether the lymph nodes have cancer is one of the two biggest predictors of long-term outcome. The other is how deep the cancer has grown.
Where the cancer drains
Cancer in the part of the urethra closer to the outside opening drains to the lymph nodes in the groin. Cancer in the part closer to the bladder drains to lymph nodes deeper in the pelvis. This is why the workup and the surgery focus on different sets of nodes depending on where the cancer sits.
When the groins feel normal
For small, low-grade cancers near the outside of the urethra, watching the groins is fine. That means regular exams and groin ultrasound.
For higher-risk cancers in the distal urethra (deeper, higher grade, or with cancer cells inside small vessels), active checking of the groin nodes is reasonable. This idea is borrowed from penile cancer, since urethral cancer is too rare to have its own studies on this question. Two ways to check:
- Dynamic sentinel node biopsy (DSNB). A small amount of tracer is injected around the cancer. The first lymph node the cancer would reach in each groin is found and removed. If it is clean, no further surgery on that side. If it has cancer, a full groin dissection follows. The smaller surgery spares many patients the side effects of a full dissection.
- Up-front groin dissection. The other choice. Used when DSNB is not done locally with high accuracy. The surgery removes the shallow and deep groin nodes on both sides.
At a center with skilled DSNB, the sentinel route is usually better. It catches cancer well and has far fewer side effects. At a center without DSNB experience, up-front dissection may be safer.
When groin nodes can be felt
About half of felt groin nodes turn out to be cancer. The other half are swollen from the cancer or an infection at the site. A needle sample of the felt node is the first step. If it shows cancer, a full groin dissection on that side, with a check of the other side, is usually the next step.
For cancers in the proximal urethra
A pelvic node check is part of the surgery. It is done with any surgery that takes out the bladder and urethra.
Side effects of groin dissection
Groin dissection is a big operation with long-term effects. The numbers are similar to those for penile cancer:
- Leg, scrotal, or genital swelling (lymphedema). Affects 20 to 50 out of 100 patients. Often long-term. Compression, lymphedema therapy, and skin care reduce the burden.
- Wound problems (infection, breakdown). 30 to 60 out of 100.
- Lymphocele (a pocket of lymph fluid). 10 to 30 out of 100.
- Blood clots in the leg. 1 to 5 out of 100.
How strong the evidence is
The data behind the lymph node plan in urethral cancer is thinner than the data in penile cancer or bladder cancer. The approach is reasonable, but it is borrowed. Your team should say so. Ask whether your case has been reviewed at a tumor board, and whether a second opinion at a high-volume center would change the plan.
Sex, body, and the path after
Recovery takes a long time. This chapter walks through what changes and what stays the same, by operation.
What changes by treatment, in men
- After office removal, laser, or skin-applied treatment for early disease. Sex life and the way you urinate are usually kept.
- After partial removal of the urethra with reconnection. Sex and standing voiding are usually kept. The stream may change.
- After removal of the distal urethra with a new opening in the perineum (perineal urethrostomy). Feeling in the penis is kept. Erections still happen for most men. You urinate sitting down, from an opening between the scrotum and the anus. Ejaculation comes out at that opening instead of the tip of the penis. Sex with the penis is still possible. The biggest change is the new way of voiding, which most men get used to over weeks to months.
- After removal of the penis with a perineal urethrostomy. Sex with the penis is not possible. Orgasm and release still happen through the new opening. A staged surgery to build a new penis (phalloplasty) is offered at a few centers.
- After removal of the bladder, prostate, and urethra together. Trouble with erections is common. It is worse than after removing the bladder alone. Nerve-sparing surgery helps in some cases. Erection pills like sildenafil or tadalafil are fine to try. The way urine leaves the body also changes. It may use a stoma on the belly or a different setup. The bladder cancer guides on urinary drainage and stoma care cover the details.
What changes by treatment, in women
- After removal of the distal one to two thirds of the urethra. Continence is usually kept as long as the bladder neck and a short part of the urethra near the bladder are kept intact. Stress incontinence (leaking with cough or laugh) is the most common change. Sex life is usually preserved. Some women notice changes in feeling at the urethra.
- After removal of the bladder, urethra, and front wall of the vagina. Sex life changes. The vagina can be rebuilt using a piece of bowel or a flap. This can restore length and allow penetrative sex. The feeling is not the same. If the ovaries are also removed, surgical menopause follows. Hormone choices should be looked at again. The urine setup is the same as after a bladder removal for bladder cancer.
About urination after distal urethral surgery in men
A perineal urethrostomy means you sit to urinate. The opening sits between the scrotum and the anus. It is hidden by clothing and has no bag. Most men adjust to the new way of voiding over the first few weeks. Many high-volume centers can show you photos from prior patients before you decide on the operation, with identifying details blocked out. Ask for them.
About continence after distal urethral surgery in women
The most common change is leaking with cough, laugh, or exercise (stress incontinence). Pelvic floor physical therapy helps most women. A small sling procedure to support the urethra is an option if therapy is not enough. Bring up any leaking at follow-up, even if it seems minor. It is fixable, and most teams will not ask about it directly.
About urinary diversion after bigger surgery
If the operation removes the bladder, you need a new way to get urine out. One option is a small opening on the belly that drains to a bag. This is called an ileal conduit. A second option is a pouch inside the body that you empty with a catheter. A third option is a new bladder built from bowel that connects to the urethra. This is called a neobladder. The bladder cancer guides on urinary diversion and stoma care cover this in depth. Read them as you get ready for surgery.
Body image and identity
Both perineal urethrostomy and urinary diversion change how you urinate and how you feel about your body. The change hits hardest in the first weeks after dressings come off, and again at the first attempt at sex. Most patients get more comfortable with the result over six to twelve months. Starting with a sex therapist or body image counselor before that first attempt at sex tends to make it go faster.
Three things to lock down before surgery. First, who will see you for body image and sexual rehab, and when. Second, whether your center can introduce you to a patient who has had the same operation. Third, what your urinary diversion will look like day to day, including the home supplies you will need.
Partner conversations
Two subjects come up with partners: passing on HPV if the cancer is squamous, and sex after treatment.
HPV transmission
If the tumor tests positive for HPV (a stain called p16), the cancer is HPV-driven. HPV passes through sex. In any couple that has been sexually active together for years, the virus has almost certainly been shared between you long before this cancer was found. The practical question is what your partner should do about their own screening from here.
- A current partner with a cervix. Make sure cervical cancer screening is up to date. Bring up any new anal or head-and-neck symptoms. Ask about the HPV shot for an adult partner through age 45 if they did not get it.
- A current partner without a cervix. Bring up any new sores or lumps on the genitals, around the anus, or in the head and neck. Ask about the HPV shot through age 45.
- A new partner after a cancer is found. HPV does not pass when there is no active sore in the area. Condoms cut the risk. The HPV shot is a good idea for a new partner who is not vaccinated.
- For you. The shot does not treat the cancer you have now. It can lower the risk of new HPV-driven cancers at other sites (anal, head and neck, cervix, vulva, penis) and block HPV types you have not yet met. Talk it over with your team if you were not vaccinated.
Intimacy after surgery
Sex usually gets put off for three to six months after surgery. The body is often ready by about eight weeks. The two usual hold-ups are that no one has walked through what to expect, and that the partner is worried about hurting the area. One or two couples visits with a sex therapist sort out both for most patients.
Ask for the referral at treatment planning, before the operation if possible. Programs that build it into the plan see couples get back to sex sooner than programs that wait for the patient to bring it up.
If you are single
Telling a new partner what your body has been through is hard work. People who do this well share a short, direct version early in the relationship. They do not save a long medical talk for right before the first time. How the other person responds tells you a lot about them.
Most US programs do not offer sex therapy or couples counseling by default for urethral cancer. You usually have to ask. The right time is at treatment planning, before the first awkward attempt at intimacy. Your team should know who to refer you to. If they do not, ask the social worker or the survivorship clinic.
Advanced disease
For cancer that has already filled the lymph nodes, reached the pelvis, or spread to distant organs, the plan changes. Drug treatment moves to the front of the sequence.
Chemotherapy before surgery
For urothelial cancer of the urethra, chemo is often given before the big operation. This is most true when the cancer has reached the muscle layer or the prostate. The standard combos come from bladder cancer. They use a drug called cisplatin paired with one more drug. Most patients get three to four cycles. Then they go to surgery if they are still good candidates.
For squamous cancer heading to surgery, the chemo is often a combo borrowed from penile cancer. It is called TIP and uses three drugs (paclitaxel, ifosfamide, cisplatin). You get a few cycles. Then the operation comes after.
Chemotherapy plus radiation as the main treatment
For squamous distal urethral cancer, chemo plus radiation can be the main treatment in place of surgery. Chapter 6 covers the trade. For urothelial urethral cancer, this combo has a smaller track record. It is used in select cases.
If the cancer has spread to distant organs
Cancer that has reached distant organs is hard to cure. The aim shifts to controlling the cancer and protecting quality of life. Median survival on first-line drugs varies by type.
- Urothelial urethral cancer. The first chemo is a cisplatin-based combo. After it works, a drug called avelumab is given to hold the gain. Two newer choices have changed the field. The first is a drug called enfortumab vedotin. The second is enfortumab vedotin given with pembrolizumab, an immune drug. For cancers with a gene change called FGFR3, a pill called erdafitinib is an option.
- Squamous urethral cancer. Platinum-based chemotherapy is the most common first step. Adding a drug called cetuximab is sometimes done. The role of immune drugs for this type is still being studied.
- Adenocarcinoma. Each case is planned on its own. The team often borrows drug combos used for bladder cancer or for gland cancers of the gut.
Clinical trials are encouraged at every step. Urethral cancer is rare enough that most new treatments will come through trials before they reach general practice. Ask early about what is open at high-volume centers.
Palliative care belongs early
Palliative care addresses pain, nausea, fatigue, sleep, mood, and family conversations. It runs alongside cancer-directed treatment from day one. It is not hospice. Many patients turn down the referral because the word sounds like the team is giving up. Randomized trials across several cancers show that patients who get palliative care early feel better day to day, and in some studies live longer. Ask for the referral at the start, before symptoms have piled up.
Hospice is different from palliative care. Hospice is comfort care for people who are no longer pursuing treatment for cancer control. It does not mean death is imminent. Many people on hospice live longer and more comfortably than they would have without it.
Why a high-volume center matters
Urethral cancer is rare. Center experience changes what surgery is offered and how well it goes. This is one of the cancers in adult urology where a second opinion at a big center makes sense for almost any invasive case.
Why experience matters here
- Reading the MRI well. The MRI of the pelvis is the single most useful test for deciding whether organ-sparing surgery is possible. Reading it well takes practice in a cancer most radiologists rarely see.
- Knowing when organ-sparing surgery is still on the table. The line between organ-sparing surgery and a bigger one keeps moving. Surgeons who do these often are more likely to offer organ-sparing when it is still safe.
- Giving chemo plus radiation as the main treatment for squamous cancer. Only a few centers do the Nigro-style plan for the urethra well.
- Putting things back together after bigger surgery. Big operations in women include rebuilding the vagina. In men, they include rebuilding after the urethra is removed. Complex urine drainage setups also fit here. All of these go better at centers that do them often.
- Pathology review. The slides are sometimes hard to read. This is especially true when the prostate part of the urethra is involved. Big centers are more likely to have a specialist read the slides.
- Tumor board review. This is a meeting where urology, cancer doctors, radiation doctors, and pathology talk through your case together. It is the standard place for a rare cancer to be planned.
Who decides where you are treated
The US has no rule that sends urethral cancer cases to set centers. The choice falls to you and your local urologist. Markers for when a second opinion fits:
- Any invasive cancer (T1 or higher).
- Any thought of organ-sparing surgery for a distal cancer.
- Any plan to use chemo plus radiation as the main treatment.
- Any cancer near the bladder that needs a bigger operation.
- Large groin nodes, nodes on both sides, or any plan for chemo before surgery.
- Any plan to build a new penis (called phalloplasty) after the penis is removed.
How to ask your local team
Good local urologists welcome a second opinion for rare cancers, and many will help you set it up. A simple line that works: "I want to make the best choice I can for a rare cancer. Can you help me set up a second opinion at a center that sees a lot of urethral cancer?"
Start with big teaching hospitals and NCI-designated cancer centers. The American Urological Association and the National Cancer Institute can help you find one. You may have to travel. For most patients, the second opinion is one or two visits. The rest of care can stay close to home.
Surveillance and survivorship
After treatment, the work splits in two. One part is watching for any return of the cancer. The other is managing the long-term effects of treatment, which gets less attention at most US programs.
The surveillance schedule
Most cancers that come back do so in the first two years. A return at the same spot can sometimes be salvaged with more surgery. A return in the nodes or in distant organs is harder. A common schedule, adapted from bladder cancer guidelines because there is no urethral-specific schedule:
- Years 1 to 2. Clinic visit every 3 months. Exam of the urethra and both groins. Urine for cells under the microscope. Cystoscopy at 3, 6, 9, 12, and 18 months for patients who kept their urethra. CT of the chest, belly, and pelvis every 6 months for higher-risk disease.
- Years 3 to 5. Clinic visit every 6 months. Cystoscopy every 6 months for patients who kept their urethra. CT yearly.
- Years 5 to 10. One clinic visit a year. One scope a year, if it fits. One scan a year.
- Beyond 10 years. Primary care plus annual self-exam. Return to urology for any new lesion or symptom.
If your bladder was removed for bladder cancer years ago
The urethra is still at risk for a new urothelial cancer. About 5 to 10 out of 100 people get one over a lifetime. Follow-up is part of your bladder cancer plan. It uses a urine wash for cells and a quick look in the urethra each year.
If you had a groin dissection
Swelling in the leg, scrotum, or genital area can start right after surgery. It can also start months to years later. Follow-up visits should ask about it. Standard tools:
- Graduated compression stockings. Used routinely after dissection.
- Massage and wrap therapy from a trained lymphedema therapist.
- Skin care. Bacterial skin infections are more common in swollen tissue and make swelling worse. Treat any break in the skin early.
- Weight management. Extra weight worsens swelling.
- Surgical treatments for swelling are offered at a small number of centers for the right patient.
Sex and mental health after
Bring these up yourself if your visits do not cover them. A good plan asks about your sex life at each visit with a short form, offers a trial of erection pills if needed, and has a sex therapist ready for couples work. It also checks your mood with a short two-question depression check, and if that flags concerns, you get a longer check. Body image stress and mood changes hit both partners in many couples. They respond to care when teams look for them.
Other parts of life after
- Check for second cancers. If your cancer was urothelial, you have a higher risk of urothelial cancers in other parts. Those parts are the upper tract, the bladder, and the part of the urethra inside the prostate. Long-term checks of the bladder and upper tract are part of the plan. If your cancer was HPV-driven squamous, you have a higher risk of HPV cancers at other sites. Those sites are the anus, head and neck, cervix, vulva, and penis.
- Quit smoking. Smoking slows wound healing, cuts how well radiation works, and raises the risk of a second cancer. Help to quit is part of the plan.
- Peer support. Urethral cancer peer support is thin compared to other cancers. Online communities exist but are small. The most useful peer connections are often one-on-one introductions through a high-volume center. Ask.
Common questions
Questions patients in your situation often bring to a first visit.
What matters most now that I have the diagnosis?
From this point on, three things move the numbers: the full staging workup, including the MRI of the pelvis and a check of the lymph nodes; the choice of operation or chemoradiation, fit to where the tumor sits and how deep it goes; and the team you have. Your urologist can answer questions about your specific cancer using the biopsy and the imaging in front of you.
I am a woman. I thought urethral cancer only happened to men.
Urethral cancer is more common in men, but it does happen in women. The types women get are often different. Distal squamous cancer near the opening and adenocarcinoma that comes from a urethral diverticulum are the two most common types in women. Small distal cancers in women have some of the best results in the disease when they are caught early.
Will I lose my bladder?
It depends on where the cancer sits and how deep it goes. Cancers in the part of the urethra closer to the outside opening often allow surgery that keeps the bladder. Cancers in the part closer to the bladder more often require removing the bladder along with the urethra. The MRI of the pelvis is the test that usually answers this question.
What is a perineal urethrostomy, and what does it mean day to day?
The urethra is moved so that the opening is in the perineum (between the scrotum and the anus in men). You urinate sitting down. There is no external bag. Feeling in the penis is kept. Sex is usually still possible, with ejaculation coming from the new opening instead of the tip of the penis. Most men adjust over weeks to months. Many high-volume centers can show you what to expect before surgery.
Can I still have sex after this?
It depends on the operation. After office removal or partial urethrectomy, most people return to sex. The same is true after distal urethrectomy with a perineal urethrostomy. After a bigger operation that removes the bladder and urethra, the hit is bigger. Rebuilding and rehab matter more. Ask for a sex therapy referral at treatment planning, not after surgery. That way the rehab starts before the first attempt at intimacy.
My groin nodes feel normal. Why are they talking about taking some out anyway?
In higher-risk distal squamous cancers, the nodes can hide tiny cancer cells. Waiting until those nodes feel large often costs survival. The plan comes from penile cancer. Some centers offer a sentinel node biopsy. That removes only the first node the cancer would drain to. It avoids the side effects of a full removal. Other centers do a smaller or full removal. The right choice depends on the tumor and on the center.
Will I have lymphedema?
If you have a groin dissection, 1 in 4 to 1 in 2 patients develop some degree of long-term swelling in the leg, scrotum, or genital area. Compression, lymphedema therapy, skin care, and weight management reduce the burden. Some swelling shows up months or years later, so this is part of long-term care.
Why is this cancer treated the same way as anal cancer?
Squamous urethral cancer acts much like squamous anal cancer. Anal cancer has a well-studied plan called the Nigro protocol. It uses chemo drugs plus radiation. It saves the bowel. Urethral cancer is too rare to run its own large trial. So several centers have adapted the anal cancer plan as a way to save the urethra. The proof comes from smaller groups, not a large trial. Your team should walk you through the trade.
I had my bladder removed for bladder cancer years ago. Why are they checking my urethra?
After your bladder was removed, the urethra remains at risk for a new urothelial cancer. About 5 to 10 out of 100 patients develop a new cancer there over a lifetime. Catching it early matters. Surveillance is typically a urine wash for cells under the microscope and sometimes a quick look in the urethra, on the schedule your bladder cancer team uses.
My doctor mentioned a diverticulum. What does that have to do with cancer?
A urethral diverticulum is a pouch along the urethra. It is most common in women. Most pouches are not cancer. A small share hold a cancer. That cancer is often a gland-type cancer from the wall of the pouch. Any new pain, mass, or bleeding in a known pouch should be checked. That is usually done with MRI and a biopsy.
Should I get a second opinion at a high-volume center?
Yes for almost any urethral cancer past the earliest stage. It also fits any thought of organ-sparing surgery, or any plan to use chemo plus radiation as the main treatment. The same is true for any case with lumps in the groin or bulky disease. This cancer is rare, and center experience changes outcomes.
Are there clinical trials I should consider?
Yes, if you have high-risk features, spread disease, or growth after the first treatment. Most trials are built around bladder cancer or other solid tumors. They are not built around urethral cancer itself. Joining a trial is fine when you fit the rules. ClinicalTrials.gov and big-center protocols are good places to start.
Questions to ask your team
Bring this page to your next visit. These are hard questions to think up on the spot.
About my cancer
- What type of urethral cancer is this? Is it urothelial, squamous, or gland-type?
- Where in the urethra is it, and how deep does the MRI show it has gone?
- What is my stage, and what does it mean for me?
- Was my tumor tested for HPV (the p16 stain)? What did it show?
- Are there any risk features on the pathology report (high grade, cancer in vessels)?
About surgery on the primary
- Is organ-sparing surgery an option for me? Why or why not?
- If you suggest a bigger operation, would a second opinion change that?
- What will my body look like, and how will I urinate, after this operation?
- What happens to my sex life?
About chemotherapy plus radiation
- Is chemoradiation an option as the main treatment for my cancer?
- How many urethral cancers does this center treat with chemoradiation each year?
- What are the long-term effects on the urethra, the bladder, and sex?
- What is the plan if the cancer does not respond?
About the lymph nodes
- What is my risk of microscopic cancer in the groin or pelvic nodes?
- Do you offer dynamic sentinel node biopsy here? How many a year?
- If not, is up-front dissection the right plan, or should I look at DSNB elsewhere?
- What are the long-term side effects, especially swelling, that I should expect?
About specialty care
- How many urethral cancer cases does this program see in a year?
- Would a referral or second opinion at a big center help in my case?
- Has my case been reviewed at a multidisciplinary tumor board?
- Which parts of my plan come from urethral cancer data, and which parts are borrowed from bladder, penile, or anal cancer?
About life after treatment
- Can I get a referral to sex therapy or couples care now, not later?
- Who will help with lymphedema if I have a groin dissection?
- Is there a mental health screen at survivorship visits?
- Is there a peer-support contact you can introduce me to?
About partners and family
- What should I say to my partner about HPV?
- Should my partner be vaccinated against HPV?
- Are my children at increased risk because I have this cancer?
Words to know
General cancer words live in the Cancer Basics guide. These are the ones used most in urethral cancer care.
- Urethra
- The tube that carries urine from the bladder out of the body.
- Distal urethra
- The part of the urethra closer to the outside opening.
- Proximal urethra
- The part of the urethra closer to the bladder.
- Meatus
- The outside opening of the urethra.
- Bulbar urethra (men)
- The part of the male urethra in the perineum, between the penile urethra and the urethra running through the prostate. The most common site of male squamous urethral cancer.
- Prostatic urethra (men)
- The part of the male urethra that runs through the prostate. The most common site of male urothelial urethral cancer.
- Urothelial cancer
- Cancer of the lining cells of the urinary tract. The most common type of urethral cancer overall.
- Squamous cell cancer
- Cancer of the surface cells of skin and lining. The most common type in the distal urethra in both sexes.
- Adenocarcinoma
- Cancer from gland cells. In the urethra, often from small glands alongside the urethra, especially inside a urethral diverticulum in women.
- Urethral diverticulum
- A pouch along the urethra. Most common in women. Can rarely harbor a cancer.
- Stricture
- A scar narrowing of the urethra. Long-term stricture is a risk factor for squamous urethral cancer.
- HPV (human papillomavirus)
- A sexually transmitted virus. HPV-16 is the main type linked to squamous urethral cancer.
- p16
- A protein stain on tumor tissue used as a marker for HPV-driven biology.
- Cystoscopy
- Looking inside the urethra and bladder with a thin camera.
- TNM
- The tumor, node, and metastasis staging system.
- Distal urethrectomy
- Removal of the part of the urethra closer to the outside opening.
- Partial urethrectomy
- Removal of a segment of the urethra with reconnection.
- Perineal urethrostomy
- A new opening for the urethra in the perineum, created after distal or total urethrectomy in men. Voiding is seated.
- Radical cystoprostatectomy with urethrectomy
- Removal of the bladder, prostate, and urethra together. Used for proximal or locally advanced male urethral cancer.
- Anterior pelvic exenteration
- Removal of the bladder, urethra, and front wall of the vagina (sometimes with the uterus and ovaries). Used for proximal or locally advanced female urethral cancer.
- Urinary diversion
- Surgical reconstruction of the way urine leaves the body after the bladder is removed. Forms include an ileal conduit, a continent cutaneous diversion, and a neobladder.
- Inguinal lymph node dissection (ILND)
- Removal of lymph nodes in the groin.
- Dynamic sentinel node biopsy (DSNB)
- A technique that removes only the first lymph node the cancer would drain to in each groin.
- Pelvic lymph node dissection
- Removal of lymph nodes deeper in the pelvis.
- Lymphedema
- Long-term swelling from disrupted lymph drainage.
- Nigro protocol
- A chemotherapy regimen (5-FU and mitomycin C) plus radiation, first developed for anal cancer and adapted for distal squamous urethral cancer.
- TIP
- A chemotherapy combination (paclitaxel, ifosfamide, cisplatin) used before surgery for advanced squamous disease, borrowed from penile cancer.
- Enfortumab vedotin
- An antibody-drug treatment used for advanced urothelial cancer.
- Avelumab
- An immune drug used as maintenance after first-line chemotherapy in advanced urothelial cancer.
- Erdafitinib
- A pill used for urothelial cancers with a specific gene change (FGFR3).
- Pembrolizumab
- An immune drug used in advanced urothelial cancer, often combined with enfortumab vedotin.
- Palliative care
- Care for symptoms and quality of life, alongside cancer treatment. Not hospice.
- Hospice
- Comfort care when treatment for cancer control is no longer being pursued.
Sources and further reading
This guide draws on current EAU and US guidelines, plus the major studies that shape care today. Where urethral-specific evidence is thin, we name the borrowed sources too.
- EAU Guidelines on Primary Urethral Carcinoma (2024 update). uroweb.org
- NCCN Bladder Cancer Guidelines, V.3.2025 (includes urethral cancer section). nccn.org
- AJCC Cancer Staging Manual, 8th Edition. cancerstagingatlas.org
- Gakis et al. EAU Guidelines on Primary Urethral Carcinoma (Eur Urol 2013). pubmed.gov
- Rabbani. Prognostic factors in primary urethral carcinoma (Urol Oncol 2011). pubmed.gov
- Swartz et al. Incidence of primary urethral cancer in the United States (Urology 2006). pubmed.gov
- Dayyani et al. Outcomes after multimodal treatment of locally advanced urethral cancer (Cancer 2014). pubmed.gov
- Kent et al. Combined chemoradiation as primary treatment for invasive male urethral cancer (J Urol 2015). pubmed.gov
- Dimarco et al. Surgical treatment for local control of female urethral carcinoma (BJU Int 2004). pubmed.gov
- Mohan et al. Urethral stricture and squamous cell carcinoma (BJU Int 2003). pubmed.gov
- Stein et al. Urethral recurrence after cystectomy (J Urol 1998). pubmed.gov
- Tholken et al. Urethral diverticulum and associated malignancy (Eur Urol 2018). pubmed.gov
- Gourtsoyianni et al. MRI of urethral cancer (Insights Imaging 2017). pubmed.gov
- Powles et al. Avelumab maintenance in advanced urothelial cancer (NEJM 2020). JAVELIN Bladder 100.
- Powles et al. Enfortumab vedotin plus pembrolizumab in advanced urothelial cancer (NEJM 2024). EV-302.
- NCI Urethral Cancer Treatment (PDQ). cancer.gov
- American Cancer Society: Urethral Cancer. cancer.org
- Get Palliative Care: What is palliative care? getpalliativecare.org
- ClinicalTrials.gov. clinicaltrials.gov
- National Lymphedema Network. lymphnet.org
About this guide. Written by the WellPrept Clinical Team. Reviewed by board-certified urologists. The numbers and choices here are the starting point for a conversation with your own care team, who can apply them to your biopsy, imaging, and history. Bring this guide and the questions in Chapter 14 to your next visit.